瘤特征预测永久的hypoparathyroidism为乳头甲状腺癌的全甲状腺切除术后:来自中国的一项研究
Yu-Jing Weng1, Zhi-Heng Huang1, Lei Min1
1Department of Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Gland surgery
|January 8, 2026
概括
瘤的侵入性,特别是甲状腺外延伸和淋巴结的参与,预测在为乳头甲状腺癌进行全甲状腺切除术后的永久性甲状腺功能低下症. 谨慎的手术技术对于保存副甲状腺腺体至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 手术病理学手术病理学
背景情况:
- 乳头甲状腺癌 (PTC) 是最常见的内分泌恶性瘤.
- 整体甲状腺切除术是晚期PTC的标准治疗方法,但存在风险.
- 永久性副甲状腺功能障碍是一种严重的并发症,影响生活质量.
研究的目的:
- 为了确定PTC全甲状腺切除术后永久性甲状腺功能低下的瘤预测因素.
- 评估瘤特征与长期副甲状腺功能障碍之间的关联.
- 为了告知外科手术策略,以减轻PTC患者的偏偏甲状腺症风险.
主要方法:
- 对367名接受全甲状腺切除术的PTC患者进行了回顾性队列研究.
- 收集关于临床,外科和病理参数的数据.
- 多变量逻辑回归用于识别永久性缺甲状腺症的独立预测因子 (定义为持续时间>6个月).
主要成果:
- 永久性偏偏甲状腺功能障碍发生在7.36%的患者中.
- 确定了独立的预测因素:毛额甲状腺外延伸 (ETE),病理中甲状腺组织的存在,以及更多的参与的中央淋巴结 (CLNs).
- 几率比:ETE (3.584),甲状腺组织 (3.809),CLN (1.147每节点).
结论:
- 瘤侵入性和手术复杂性是PTC甲状腺切除术后永久性甲状腺缺血症的关键因素.
- 总体ETE和广泛的CLN参与需要仔细的甲状腺腺保护.
- 研究结果强调,在高风险的PTC病例中进行广泛切除时需要提高警.
相关概念视频
The Parathyroid Glands
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...


